ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Westminster
State: Colorado
Zip:
Country: United States
ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases. ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/1/2009
Ticker Symbol:
ABIO
Amount Raised:
$100M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2013 | Post-IPO Equity | $1.3M | 6/2007 | Series B | 5 | $18M |
The Peierls Foundation InterWest Partners Skyline Ventures Atlas Venture Boulder Ventures Skyline Ventures The Peierls Foundation InterWest Partners Skyline Ventures Atlas Venture Boulder Ventures Skyline Ventures |
3/2006 | Series A | 3 | $15M |
Atlas Venture Pequot Capital Boulder Ventures Atlas Venture Atlas Venture Pequot Capital Boulder Ventures Atlas Venture |
6/2015 | Post-IPO Equity | $51.7M | 1/2012 | Post-IPO Equity | $4.5M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|